DE69113871T2 - Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen. - Google Patents

Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen.

Info

Publication number
DE69113871T2
DE69113871T2 DE69113871T DE69113871T DE69113871T2 DE 69113871 T2 DE69113871 T2 DE 69113871T2 DE 69113871 T DE69113871 T DE 69113871T DE 69113871 T DE69113871 T DE 69113871T DE 69113871 T2 DE69113871 T2 DE 69113871T2
Authority
DE
Germany
Prior art keywords
hypertriglyceridemia
hydroxyphenylthio
bis
compound
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69113871T
Other languages
German (de)
English (en)
Other versions
DE69113871D1 (de
Inventor
Richard L Jackson
George Ku
Simon J T Mao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69113871D1 publication Critical patent/DE69113871D1/de
Application granted granted Critical
Publication of DE69113871T2 publication Critical patent/DE69113871T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69113871T 1990-06-19 1991-06-18 Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen. Expired - Fee Related DE69113871T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/540,657 US5122542A (en) 1990-06-19 1990-06-19 Hypotriglyceridemic use of certain bis (3,5-di-alkyl-4-hydroxyphenylthio)methanes

Publications (2)

Publication Number Publication Date
DE69113871D1 DE69113871D1 (de) 1995-11-23
DE69113871T2 true DE69113871T2 (de) 1996-04-04

Family

ID=24156398

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69113871T Expired - Fee Related DE69113871T2 (de) 1990-06-19 1991-06-18 Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen.

Country Status (13)

Country Link
US (1) US5122542A (OSRAM)
EP (1) EP0462556B1 (OSRAM)
JP (1) JPH04230213A (OSRAM)
KR (1) KR0168649B1 (OSRAM)
AT (1) ATE129151T1 (OSRAM)
AU (1) AU640486B2 (OSRAM)
DE (1) DE69113871T2 (OSRAM)
DK (1) DK0462556T3 (OSRAM)
ES (1) ES2080854T3 (OSRAM)
GR (1) GR3018351T3 (OSRAM)
IE (1) IE69315B1 (OSRAM)
TW (1) TW205542B (OSRAM)
ZA (1) ZA914538B (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063408A1 (en) * 2004-12-17 2006-06-22 Stocker Ronald O Compositions and methods for treating cardiovascular disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734527A (en) * 1986-10-17 1988-03-29 Merrell Dow Pharmaceuticals Inc. Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol
US4954528A (en) * 1988-12-08 1990-09-04 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic use of bis(3,5-di-tertiary-butly-4-hydroxyphenylthio)methane
US4900757A (en) * 1988-12-08 1990-02-13 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane
US4959392A (en) * 1989-07-24 1990-09-25 Merrell Dow Pharmaceuticals Inc. Method of treating diabetes mellitus

Also Published As

Publication number Publication date
DE69113871D1 (de) 1995-11-23
DK0462556T3 (da) 1995-11-27
AU7836591A (en) 1992-01-02
JPH04230213A (ja) 1992-08-19
IE912087A1 (en) 1992-01-01
EP0462556A2 (en) 1991-12-27
TW205542B (OSRAM) 1993-05-11
EP0462556A3 (en) 1992-03-11
ATE129151T1 (de) 1995-11-15
AU640486B2 (en) 1993-08-26
KR920000327A (ko) 1992-01-29
IE69315B1 (en) 1996-09-04
ZA914538B (en) 1992-03-25
ES2080854T3 (es) 1996-02-16
GR3018351T3 (en) 1996-03-31
KR0168649B1 (ko) 1999-01-15
EP0462556B1 (en) 1995-10-18
US5122542A (en) 1992-06-16

Similar Documents

Publication Publication Date Title
DE68903215T2 (de) Hypocholesterolaemische und antiatherosklerotische verwendung von bis-(3,5-di-tertiaerbutyl-4-hydroxyphenylthio)methan.
Bernsen et al. Treatment of complex I deficiency with riboflavin
DE69829966T2 (de) Ein monoether von probucol und methoden zur hemmung der vcam-1 expression
MESSINGER et al. Effect of feeding egg yolk and cholesterol on serum cholesterol levels
JPS60224697A (ja) チゴゲニンセロビオシドおよび医薬
DE69434720T2 (de) Verwendung von 2,6-Dialkyl-4-Silyl-Phenol Derivaten zur Behandlung von Xanthom
Drenser et al. Crystalline retinopathies
NL8602933A (nl) Geneesmiddel voor het behandelen van dementie.
DE3429551A1 (de) Pharmazeutische zubereitung, die ein glycoprotein enthaelt
US4229439A (en) Method of treatment of atheroma
DE69113871T2 (de) Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen.
DE69016866T2 (de) Verwendung von Bis(4-hydroxyphenylthio)methan-Derivaten zur Behandlung von Diabetes mellitus.
EP0319288B1 (en) dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
DE69526731T2 (de) Hypocholesterolämische,antiatherosklerotische und hypotriglyceridämische mercaptoacetylamid-derivate
AU610611B2 (en) Use of c-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
DE69214180T2 (de) Verwendung von Bis-(p-Hydroxyphenylthio)methanderivaten zur Hemmung der fortschreitenden Entwicklung von insulinabhängingem Diabetes mellitus
DE69021664T2 (de) Verwendung von bisphenol-Derivaten zur Behandlung von Diabetes mellitus.
DE60027760T2 (de) Verwendung von substituierten nitrobenzol derivaten zur behandlung von erkrankungen verursacht von bakterien, pilzen und viren
DE3417573A1 (de) Arzneimittel mit lipoxygenase hemmender wirkung
EP0087744B1 (en) Lipid metabolism improving agents
DE69531489T2 (de) Cholesterin senkende mercaptoacetylamiddisulfidderivate
Eisenberg Type III hyperlipoproteinaemia
US4151281A (en) Medicinal preparation for the treatment of collagenoses of a rheumatoid nature
Samorajski et al. Dihydroergotoxine and Ethanol: Physiological and Neurochemical Variables in Male Mice
FR2602143A1 (fr) Utilisation du diethylaminoethyldextran pour la fabrication d'un medicament destine a reduire l'hyperglycemie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee